ArticleAllergy2019
Serum CXCL9 as a potential marker of Type 1 inflammation in the context of eosinophilic asthma.
Takehiro Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleAllergy2019
Takehiro Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.